Guangzhou Hanke Biological

Guangzhou Hanke Biological is a clinical-stage biotechnology company based in Guangzhou, China, specializing in the development of innovative cell therapies. The company focuses on Natural Killer (NK) cell-based treatments, utilizing its proprietary platform for the large-scale expansion and genetic modification of NK cells. Its pipeline includes non-modified NK cells and Chimeric Antigen Receptor (CAR)-NK cells targeting various solid tumors and hematological malignancies. Hanke Biological aims to overcome the limitations of current immunotherapies by providing off-the-shelf cell products with enhanced safety and efficacy profiles. The company operates a GMP-compliant manufacturing facility to support its clinical trials and future commercialization efforts.